| Net Cash Provided by (Used in) Operating Activities |
$407,426,000 |
USD |
3.9% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$118,225,000 |
USD |
-402% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$264,558,000 |
USD |
35% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
270,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
97,265,559 |
shares |
-1.9% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$24,643,000 |
USD |
1.5% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$14,299,000 |
USD |
60% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$41,888,000 |
USD |
16% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$1,442,000 |
USD |
-20% |
Q4 2025 |
FY 2025 |
| Property, Plant and Equipment, Gross |
$11,257,974,000 |
USD |
18% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$46,646,000 |
USD |
1590% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$136,682,000 |
USD |
17% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Current Income Tax Expense (Benefit) |
$3,015,000 |
USD |
300% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2025 |
FY 2025 |
| Interest Expense |
$143,446,000 |
USD |
55% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
|
Q3 2024 |
Q3 2024 |